Orris

What are different phases of organophosphorus poisonings

Reading File
Organophosphorus (OP) poisoning classically presents in phases related to cholinergic excess from acetylcholinesterase inhibition. Let me search the library for detailed coverage.
Searching sources...
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive information from the textbooks. Here is the detailed answer:

Phases / Clinical Syndromes of Organophosphorus (OP) Poisoning

OP compounds inhibit acetylcholinesterase by phosphorylation, causing acetylcholine accumulation at synapses and neuromuscular junctions. Four well-defined clinical syndromes follow OP exposure, as described in Tintinalli's Emergency Medicine and Bradley and Daroff's Neurology.

Phase 1: Acute Cholinergic Crisis

Timing: Within minutes to 24 hours of exposure (most symptomatic within 8 hours; nearly all within 24 hours)
This is the classic "cholinergic toxidrome" resulting from excess acetylcholine at muscarinic, nicotinic, and CNS receptors.
Muscarinic effects (mnemonic: SLUDGE / DUMBELS / "Killer Bs"):
  • Salivation, Lacrimation, Urinary incontinence, Defecation, GI cramps, Emesis (SLUDGE)
  • Bradycardia, Bronchorrhea, Bronchospasm - the "Killer Bs" - these cause most deaths
  • Miosis
Nicotinic effects (at neuromuscular junctions and sympathetic ganglia):
  • Muscle fasciculations, cramps, weakness
  • Diaphragm and respiratory muscle weakness - can lead to respiratory failure
  • Tachycardia, hypertension, mydriasis, pallor (sympathetic ganglia stimulation)
  • In severe poisoning, nicotinic features may appear first
CNS effects:
  • Anxiety, restlessness, emotional lability
  • Tremor, confusion, delirium, hallucinations
  • Seizures, coma
Death in this phase is typically from respiratory failure due to bronchorrhea combined with respiratory muscle paralysis.

Phase 2: Intermediate Syndrome (IMS)

Timing: 1-5 days after acute exposure (typically 24-96 hours after the cholinergic crisis resolves)
The IMS occurs in up to 40% of patients following ingestion. It reflects prolonged nicotinic receptor stimulation from persistent acetylcholinesterase inhibition.
Key features:
  • Paralysis of proximal limb muscles, neck flexor muscles, cranial nerve-innervated muscles
  • Respiratory muscle paralysis - patients may require mechanical ventilation
  • Notably, signs of cholinergic excess are absent at this stage
  • EMG may assist in diagnosis
  • Resolves in approximately 7 days with supportive care
Aggressive early antidote therapy (atropine + pralidoxime) during the acute phase may prevent or reduce the severity of IMS.
IMS has not been reported after chemical warfare nerve agent (nerve gas) poisoning - only after pesticide exposures.

Phase 3: Organophosphate-Induced Delayed Neuropathy (OPIDN)

Timing: 2-5 weeks after acute exposure
Not all OP compounds cause this - it occurs only with specific agents (e.g., tri-ortho cresyl phosphate, leptophos, trichlorfon, mipafox). It is caused by phosphorylation and "aging" of neuropathy target esterase (NTE), not acetylcholinesterase.
Key features:
  • Paresthesias and cramps in the feet and calves initially
  • Progressive distal-to-proximal weakness - can lead to quadriplegia in severe cases
  • Maximum deficit develops within ~2 weeks after onset
  • Sensory complaints are often inconspicuous despite motor involvement
  • The pattern can mimic Guillain-Barre syndrome
  • No specific preventive treatment exists; management is supportive
Cognitive dysfunction, impaired memory, mood changes, autonomic dysfunction, and extrapyramidal signs can also be components of OPIDN.

Phase 4: Chronic Toxicity

Timing: Gradual onset with repeated low-level exposure (not a single acute exposure)
Seen primarily in agricultural workers with daily occupational exposure.
Key features:
  • Symmetrical sensorimotor axonopathy
  • Symptoms are often non-specific - "dippers' flu" presentation (headache, rhinitis, myalgia, flu-like symptoms)
  • No clear cholinergic syndrome
  • Neuropsychological effects: impaired neurobehavioral function (supported by meta-analyses of well-designed studies)
  • Chronic fatigue syndrome and multiple chemical sensitivity have been reported at very low doses, particularly in women

Summary Table

PhaseTimingMechanismKey Features
1. Acute Cholinergic CrisisMinutes-24 hrsAChE inhibition → ACh excessSLUDGE, Killer Bs, fasciculations, seizures, coma
2. Intermediate Syndrome (IMS)1-5 daysPersistent nicotinic receptor stimulationProximal muscle paralysis, respiratory failure, no cholinergic signs
3. Delayed Neuropathy (OPIDN)2-5 weeksNTE inhibition + "aging"Distal-to-proximal neuropathy, weakness, GBS-like
4. Chronic ToxicityRepeated exposure (weeks-months)Cumulative cholinesterase suppressionNon-specific symptoms, sensorimotor axonopathy, neurobehavioral changes
Treatment highlights:
  • Atropine - reverses muscarinic effects (does NOT reverse nicotinic/neuromuscular effects)
  • Pralidoxime (2-PAM) - reactivates AChE if given before "aging" occurs; more effective in early treatment
  • Benzodiazepines - for seizures
  • Airway/ventilation - the most critical priority; succinylcholine has prolonged effect in OP poisoning (use rocuronium instead for intubation)
Sources: Tintinalli's Emergency Medicine, pp. 1342-1343 | Bradley and Daroff's Neurology in Clinical Practice, pp. 1812-1813 | Rosen's Emergency Medicine, p. 1511
This is a shared conversation. Sign in to Orris to start your own chat.